Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies
Publication
, Journal Article
Segura, T
Published in: Handbook of Pharmaceutical Biotechnology
2007
Duke Scholars
Published In
Handbook of Pharmaceutical Biotechnology
Publication Date
2007
Start / End Page
1013 / 1059
Publisher
John Wiley & Sons, Inc.
Citation
APA
Chicago
ICMJE
MLA
NLM
Segura, T. (2007). Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies. Handbook of Pharmaceutical Biotechnology, 1013–1059.
Segura, Tatiana. “Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies.” Handbook of Pharmaceutical Biotechnology, 2007, 1013–59.
Segura T. Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies. Handbook of Pharmaceutical Biotechnology. 2007;1013–59.
Segura, Tatiana. “Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies.” Handbook of Pharmaceutical Biotechnology, John Wiley & Sons, Inc., 2007, pp. 1013–59.
Segura T. Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies. Handbook of Pharmaceutical Biotechnology. John Wiley & Sons, Inc.; 2007;1013–1059.
Published In
Handbook of Pharmaceutical Biotechnology
Publication Date
2007
Start / End Page
1013 / 1059
Publisher
John Wiley & Sons, Inc.